摘要
目的观察氨溴索雾化吸入联合阿奇霉素治疗小儿支原体肺炎的临床疗效。方法 48例小儿支原体肺炎患者随机分为两组。对照组(24例)采用阿奇霉素治疗,联合治疗组(24例)在对照组治疗基础上加用氨溴索雾化吸入。治疗结束后,观察两组临床治疗总有效率和临床体征消失时间。结果联合治疗组治疗总有效率为83.33%,明显高于对照组总有效率66.67%(P<0.05);联合治疗组患者各临床体征,如肺部哮鸣音、咳嗽喘憋平均消失时间和退热时间较对照组缩短明显(P<0.05)。结论氨溴索雾化吸入联合阿奇霉素治疗小儿支原体肺炎疗效显著,副作用少,值得临床推广应用。
Objective To observe the curative effect of ambroxol atomization inhalation combined with azithromycin on treatment of children with mycoplasma pneumonia.Methods 48 cases of mycoplasma pneumonia children were randomly divided into two groups.Control group（24 cases） was treated by azithromycin,and the union treatment group（24 cases） was treated by ambroxol atomization inhalation at the base of control groups.Comparing clinical observation and treatment efficiency,clinical signs disappeared time.Results The total effective rate of union treatment group was 83.33% and the control group 66.67%,with significant difference（P0.05）.The recovery time of clinical signs in union treatment group including lungs wheeze,cough,wheezing,and fever clearance were shorter than those in the control group（P0.05）.Conclusion The combination of ambroxol atomization inhalation and azithromycin on treatment of children with mycoplasma pneumonia had a good effect,no adverse effection,which should be valuable to widespread popularization.
出处
《临床肺科杂志》
2011年第11期1684-1685,共2页
Journal of Clinical Pulmonary Medicine
关键词
氨溴索
雾化
阿奇霉素
支原体肺炎
ambroxol
atomization
azithromycin
mycoplasma pneumonia
